Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)
Sponsor: Merck Sharp & Dohme LLC
Summary
The goal of this trial is to measure what happens to 1 or 2 doses of MK-2828 in a person's body over time (pharmacokinetic or PK trial). Researchers want to learn if the PK of people with certain types of kidney disease is similar to the PK of healthy people.
Official title: An Open-Label, Single-Dose Clinical Study to Evaluate the Pharmacokinetics of MK-2828 in Participants With Renal Impairment
Key Details
Gender
All
Age Range
24 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2026-03-02
Completion Date
2026-08-18
Last Updated
2026-04-02
Healthy Volunteers
Yes
Interventions
MK-2828
Oral administration
Locations (3)
Panax Clinical Research ( Site 0003)
Miami Lakes, Florida, United States
Floridian Clinical Research ( Site 0001)
Miami Lakes, Florida, United States
Orlando Clinical Research Center ( Site 0002)
Orlando, Florida, United States